Trials / Enrolling By Invitation
Enrolling By InvitationNCT04482660
Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Barcelonabeta Brain Research Center, Pasqual Maragall Foundation · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
This study will characterize tau tracer retention by Positron Emission Tomography (PET) as a function of amyloid levels transversally and longitudinally.
Detailed description
CROSS-SECTIONAL OBJECTIVES * To measure 18F-RO6958948 retention in selected participants of ALFA-related studies as a function of amyloid levels. * To study the relation between 18F-RO6958948 retention and amyloid levels. * To characterize imaging correlates as a function of tau and amyloid levels. * To study the role of tau retention on cognitive performance. * To define predictors of tau retention. LONGITUDINAL OBJECTIVES * To measure tau accumulation and spreading in participants of the ALFA-related studies of BBRC as a function of baseline amyloid levels. * To study the dynamic relation between tau spreading and amyloid levels longitudinally. * To define predictors of tau spreading.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Positron emission tomography with 18F-RO6958948 | tau PET () |
Timeline
- Start date
- 2021-03-29
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2020-07-22
- Last updated
- 2025-05-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04482660. Inclusion in this directory is not an endorsement.